FindTrial
Sign In

Resolute Integrity

DEVICE2 trials

Sponsors

Foundation of Cardiovascular Research and Education Enschede, Seoul National University Bundang Hospital

Conditions

Acute Coronary SyndromeAngina PectorisAngina, UnstableCoronary Artery DiseaseCoronary Heart DiseaseCoronary RestenosisCoronary StenosisMyocardial Infarction

Phase 4

Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent
CompletedNCT01826552
Seoul National University Bundang HospitalCoronary Artery Disease, Coronary Heart Disease, Non-ST-segment Elevation Myocardial Infarction +3
Start: 2013-09-30End: 2015-06-30Updated: 2016-04-20

Unknown Phase

Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)
CompletedNCT01674803
Foundation of Cardiovascular Research and Education EnschedeAcute Coronary Syndrome, Angina Pectoris, Angina, Unstable +4
Start: 2012-12-21End: 2020-08-25Updated: 2022-07-20

Related Papers

Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease - a secondary analysis of the randomized TWENTE trials.
2025-07-061 citations
Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease
Cardiovascular Intervention and Therapeutics2024-12-195 citations
Premature coronary artery disease in all-comers undergoing first PCI
European Heart Journal2023-11-01
First myocardial infarction in patients with premature coronary artery disease: insights into patient characteristics and outcome after treatment with contemporary stents
European Heart Journal Acute Cardiovascular Care2023-08-224 citations
Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials
Cardiovascular Diagnosis and Therapy2023-08-012 citations
Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention
Frontiers in Cardiovascular Medicine2023-06-195 citations
Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers
Journal of the American Heart Association2022-11-0829 citations
Clinical outcome up to 2 years after percutaneous coronary intervention in all-comers with concomitant symptomatic peripheral arterial disease: a pooled analysis in 9,204 randomized trial participants
European Heart Journal2022-10-01
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials
Cardiovascular Diabetology2021-10-3026 citations
Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial
Catheterization and Cardiovascular Interventions2020-04-0118 citations
1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.
2020-04-018 citations
Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study
Catheterization and Cardiovascular Interventions2019-10-1712 citations
Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.
2019-08-1447 citations
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels
JAMA Cardiology2019-05-2170 citations
High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial.
2018-12-016 citations
Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial.
2018-10-0137 citations
"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
2018-02-1419 citations
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
2016-10-30187 citations
Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial.
2013-11-205 citations